Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06264128 · ClinicalTrials.gov registry record · NA
TPAP for Comfort in OSA
A NA study, sponsored by SleepRes.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT06264128 is a NA study that has completed, run by SleepRes. The registered enrollment target is 150 participants.
The verdict
NCT06264128, a NA study, has completed, sponsored by SleepRes.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
TheraPAP is a prototype device (with full documented electrical and isolation safety) being developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control algorithm that lowers the pressure from the set pressure at the beginning of inspiration and does not return the pressure to the full set level until about halfway through expiration. The present study, TheraPAP Comfort, aims at assessing whether TPAP improves patient comfort vs. CPAP during supine wakefulness.
Interventions
- DEVICE CPAP
- DEVICE TPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2024-05-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06264128
The ClinicalTrials.gov registry entry for NCT06264128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SleepRes, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CPAP is the first listed.
NCT06264128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06264128 about?
NCT06264128 is a clinical study titled "TPAP for Comfort in OSA". TheraPAP is a prototype device (with full documented electrical and isolation safety) being developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control algorithm that lowers the p...
What is the current status of trial NCT06264128?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2024-03-08. Estimated completion is 2024-05-25.
What interventions are being tested in trial NCT06264128?
The interventions under investigation include: CPAP (DEVICE), TPAP (DEVICE).
Who is sponsoring clinical trial NCT06264128?
This trial is sponsored by SleepRes, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.